Séverine Martinez

2.2k total citations · 1 hit paper
6 papers, 1.5k citations indexed

About

Séverine Martinez is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Séverine Martinez has authored 6 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Séverine Martinez's work include Neuroblastoma Research and Treatments (2 papers), Cancer Genomics and Diagnostics (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). Séverine Martinez is often cited by papers focused on Neuroblastoma Research and Treatments (2 papers), Cancer Genomics and Diagnostics (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). Séverine Martinez collaborates with scholars based in France, Austria and United Kingdom. Séverine Martinez's co-authors include Markus Raderer, Eva Sedláčková, Jarosław B. Ćwikła, Alexandria T. Phan, Jaume Capdevila, Philippe Ruszniewski, Guido Rindi, Martyn Caplin, Edward M. Wolin and Lucy Wall and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Séverine Martinez

4 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

2014 1.3k citations Martyn Caplin, Marianne Pavel et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Séverine Martinez France	4	1.4k	1.3k	1.1k	95	70	6	1.5k
Alison Langley United Kingdom	5	1.4k 1.1×	1.3k 1.1×	1.1k 1.1×	97 1.0×	74 1.1×	12	1.5k
Staffan Welin Sweden	11	804 0.6×	731 0.6×	612 0.6×	90 0.9×	72 1.0×	15	911
Wouter T. Zandee Netherlands	15	678 0.5×	626 0.5×	512 0.5×	108 1.1×	104 1.5×	38	836
Anna Malczewska Poland	19	749 0.5×	704 0.6×	410 0.4×	36 0.4×	89 1.3×	37	902
Marianne E. Pavel Germany	5	564 0.4×	470 0.4×	369 0.3×	44 0.5×	29 0.4×	11	748
Rachel S. van Leeuwaarde Netherlands	14	425 0.3×	350 0.3×	294 0.3×	99 1.0×	61 0.9×	43	556
Jan-Paul Esser Netherlands	5	606 0.4×	485 0.4×	422 0.4×	45 0.5×	35 0.5×	6	751
Maribel Lopera Sierra United States	9	514 0.4×	452 0.4×	353 0.3×	65 0.7×	36 0.5×	24	640
Beth Chasen United States	11	369 0.3×	343 0.3×	261 0.2×	42 0.4×	78 1.1×	19	557
Sven‐Petter Haugvik Norway	13	364 0.3×	419 0.3×	213 0.2×	18 0.2×	100 1.4×	21	525

Countries citing papers authored by Séverine Martinez

Since Specialization

Citations

This map shows the geographic impact of Séverine Martinez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Séverine Martinez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Séverine Martinez more than expected).

Fields of papers citing papers by Séverine Martinez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Séverine Martinez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Séverine Martinez. The network helps show where Séverine Martinez may publish in the future.

Co-authorship network of co-authors of Séverine Martinez

This figure shows the co-authorship network connecting the top 25 collaborators of Séverine Martinez. A scholar is included among the top collaborators of Séverine Martinez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Séverine Martinez. Séverine Martinez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Corre, R., J.B. Auliac, J. Pinsolle, et al.. (2023). 1420P Real-life management of octogenarians with NSCLC in a French nationwide cohort. Annals of Oncology. 34. S811–S811.

2.

Dalban, Cécile, Jean‐Sébastien Frenel, Michel Fabbro, et al.. (2022). Ribosome biogenesis‐based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group. Molecular Oncology. 17(1). 27–36. 3 indexed citations

3.

Ortiz‐Cuaran, Sandra, Aurélie Swalduz, Séverine Martinez, et al.. (2018). Abstract 937: Longitudinal circulating-tumor DNA profiling of EGFR-mutated non-small cell lung cancer patients treated with EGFR-tyrosine kinase inhibitors. Cancer Research. 78(13_Supplement). 937–937.

4.

Swalduz, Aurélie, Sandra Ortiz‐Cuaran, Virginie Avrillon, et al.. (2018). Fusion detection and longitudinal circulating tumor DNA (ctDNA) profiling in ALK+ non-small cell lung cancer (NSCLC) patients.. Journal of Clinical Oncology. 36(15_suppl). e21031–e21031. 3 indexed citations

5.

Caplin, Martyn, Marianne Pavel, Jarosław B. Ćwikła, et al.. (2016). Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study. Endocrine Related Cancer. 23(3). 191–199. 170 indexed citations

6.

Caplin, Martyn, Marianne Pavel, Jarosław B. Ćwikła, et al.. (2014). Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors. New England Journal of Medicine. 371(3). 224–233. 1286 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact